EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Sep. 7, 2012-- SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification technologies to the healthcare industry, announced today that it will participate in CL King's 10th Annual Best Ideas Conference in New York City on Wednesday, September 12, 2012. Gary Maharaj, SurModics’ President and Chief Executive Officer, and Timothy Arens, Vice President of Finance and interim Chief Financial Officer, will discuss the Company’s strategy and business conditions during a formal presentation beginning at 10:00 am EDT.

The presentation will be available via webcast by visiting the investor relations portion of the Company's website at www.surmodics.com on the day of the Conference and clicking the webcast icon. In addition, the Conference audio and slide presentation will be archived on the Company's website following the meeting.

About SurModics, Inc.

SurModics’ mission is to exceed our customers’ expectations and enhance the well-being of patients by providing the world’s foremost, innovative surface modification technologies and in vitro diagnostic chemical components. The Company partners with the world’s leading and emerging medical device, diagnostic and life science companies to develop and commercialize innovative products designed to improve patient diagnosis and treatment. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and microarrays. SurModics is headquartered in Eden Prairie, Minnesota.

Source: SurModics, Inc.

SurModics, Inc.
Tim Arens, 952-500-7000
Vice President of Finance and Interim Chief Financial Officer